Cancer disparities are evident across the Human Development Index (HDI) and are projected to increase by 2050.
Soft multifocal lenses show promise as a management tool for accommodation and vergence disorders in patients without presbyopia.
The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.
The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.